Literature DB >> 3924669

The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization.

S J Muasher, J E Garcia, Z Rosenwaks.   

Abstract

One hundred fifty-one cycles in 134 consecutive patients were stimulated with 150 IU of human urinary follicle-stimulating hormone (FSH) and 150 IU of human menopausal gonadotropin (hMG) on cycle days 3 and 4 and then with 150 IU of hMG daily for the purpose of multiple follicular development for in vitro fertilization (IVF). Seventy-three patients did not have a prior IVF attempt, and 61 patients in 78 cycles had prior IVF attempts at least once with their previous cycles stimulated with the same method and/or hMG and/or FSH. There was an average of three preovulatory oocytes retrieved per laparoscopy and a pregnancy rate of 27% per transfer cycle. The results were equally favorable in "new" and "old" patient cycles. The pregnancy rate increased with the transfer of two or more conceptuses of preovulatory origin. The multiple pregnancy rate, but not the abortion rate, increased with increased numbers of conceptuses transferred.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924669     DOI: 10.1016/s0015-0282(16)48678-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

1.  Ovarian stimulation for in vitro fertilization in low-responder patients using pulsatile intravenous follicle stimulating hormone.

Authors:  M C Edelstein; R G Brzyski; G S Jones; S J Muasher
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-10

2.  Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients.

Authors:  M C Edelstein; R G Brzyski; G S Jones; S Oehninger; S M Sieg; S J Muasher
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-06

3.  The use of follicle-stimulating hormone for controlled ovarian hyperstimulation in in vitro fertilization.

Authors:  D Navot; Z Rosenwaks
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-02

Review 4.  Low- versus high-dose human menopausal gonadotropin in an in vitro fertilization-embryo transfer program.

Authors:  T Levy; Z Ben-Rafael
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

5.  Plasma prorenin response to human chorionic gonadotropin in ovarian-hyperstimulated women: correlation with the number of ovarian follicles and steroid hormone concentrations.

Authors:  J Itskovitz; J E Sealey; N Glorioso; Z Rosenwaks
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

6.  Full physiological maturation in vitro of immature mouse oocytes induced by sequential treatment with follicle-stimulating hormone and luteinizing hormone.

Authors:  M Jinno; B A Sandow; R Iizuka; G D Hodgen
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-10

7.  High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization.

Authors:  G E Hofmann; J P Toner; S J Muasher; G S Jones
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-10

8.  Impact of leuprolide acetate on the response to follicular stimulation for in vitro fertilization in patients with normal basal gonadotropin levels.

Authors:  R G Brzyski; G S Jones; S Oehninger; A A Acosta; C H Kruithoff; S J Muasher
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-10

9.  Follicle stimulating hormone levels on cycle day 3 predict ovulation stimulation response.

Authors:  A Ebrahim; G Rienhardt; S Morris; T F Kruger; C J Lombard; J P Van der Merwe
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

10.  Monitoring gonadotropin-stimulated cycles for in vitro fertilization and embryo transfer.

Authors:  D Kreiner; S J Muasher; A A Acosta; G S Jones; H C Liu; Z Rosenwaks
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.